Previous Struggle: CGM falling off during exercise, unable to access phone and cannot hear alerts.
Favorite Eversense Benefit: “I don’t worry about wasting a sensor if I’m too sweaty for my CGM to stay on my skin.”
Less device frustrations. More reasons to switch.
Say goodbye to short-term, 7-14 day CGMs that need constant changing and maintenance. Switch to the only long-term CGM designed to give you more convenience and reliability.
Fewer Wasted Sensors
Sensors failing or falling off cost time, money and readings. Our implantable sensor lasts for 6 months.
Less Skin Irritation
Other CGMs use adhesives that you may find harsh on your skin. Our mild, silicone-based adhesives are gentle and are changed daily.
Alerts You Can Trust
Get exceptional accuracy with 99% of high and 94% of low glucose events1 detected correctly and essentially no compression lows.2
More Discretion
Removable smart transmitter can be taken off* when desired, plus on-body vibe alerts keep your notifications discreet.
The Eversense System
The difference is inside. See how Eversense E3 gives you 6 months of real-time, reliable glucose readings, from a small sensor under the skin in your upper arm.
Tiny Implantable 6 Month Sensor
KEY DETAILS
Only one sensor placement and warm-up period every 6 months
Sensor lasts 6 months with exceptional, consistent accuracy3
Implantable so the sensor stays comfortably in place without risk of falling out or being knocked off
Essentially no compression lows due to the sensor sitting under the skin2
Remarkable glucose event detection rates: 99% of high and 94% of low glucose events detected correctly1
Removable Smart Transmitter
KEY DETAILS
The only CGM with removable smart transmitter*
Receives readings every 5 minutes whether or not you have your mobile device
Water-resistant submerged in 1 meter of water for up to 30 minutes
Attaches to the body with gentle adhesive
Provides distinct on-body vibe alerts when high or low, allowing you to get alerts even when you are away from your phone or smart device
Gentle Adhesive
KEY DETAILS
Silicone-based
Can change daily for fresh wear
Available in both clear and white color options
Mobile App & Alerts
KEY DETAILS
The only app with both high and low predictive alerts, so you know in advance if your glucose is moving toward a high or low event
Share real-time data from the Eversense app with your Health Care Provider without lengthy downloads, plus up to 5 friends and family through the Eversense Now app
View summary reports to better understand your glucose levels and trends
Looking for more reasons to switch?
Here are a few ways Eversense E3 outlasts and outperforms short-term CGMs.
Eversense E3
Other CGMs
Sensor life
6 months
7-14 days
Sensor changes per year
2
26-52
Day 1 warmup periods
2
26-52
Insertion by trained professional
Yes
No
Transmitter can be removed and put back on without wasting a sensor
Yes*
No
On-body alerts
Yes
No
Silicone-based fresh daily adhesive for comfort3
Yes
No
Simple Process, Continuous Support
Eversense E3 is an optimal choice for adults with T1 or T2 diabetes on insulin, including those using a non-automated insulin pump. Ready to make the switch? Get started in just a few simple steps.
Real Lives, Uninterrupted.
See the real impacts Eversense has made on those who switched from short-term CGMs.
ALL 4 ARE EVERSENSE AMBASSADORS
The Most Frequently Asked Questions
Eversense gives you real-time glucose readings through a small sensor that’s placed just under the skin of your upper arm by a healthcare professional. The smart transmitter sits above the sensor, sending glucose data to your app. Want to learn more about the science behind Eversense? Check out our “How Eversense Works” video!
Eversense E3 is the only implantable sensor for long term wear - see how we compare!
If you’re on multiple daily doses of insulin and if you answer yes to any of the below questions, you may be a great candidate for Eversense!
1. Would you prefer only 2 sensor changes a year?
2. Do you have skin irritation from the adhesive of your current CGM?
3. Are you tired of false lows/false readings or gaps in data?
4. Would you like to have the freedom to remove your CGM transmitter without wasting the sensor?
5. Do your CGM alerts sometimes disrupt those around you?
Download our discussion guide and bring it to your next appointment and talk to your doctor about how Eversense may be a better fit for your diabetes management plan. We will work with you and your health care provider to manage your insurance claim.
Depending on your specific insurance plan, there could be differences in cost. We are happy to help you navigate getting more information about your insurance coverage. Just fill out the Pre-Qualification form, and we will be happy to contact you.
Want to see if you
qualify?
Simply answer a few simple questions in a short quiz to see if Eversense is right for you.
* There is no glucose data generated when the transmitter is removed
1. Senseonics. (2023) Eversense E3 Continuous Glucose Monitoring System User Guide. LBL-6002-01-001_Rev C
2. Christiansen MP et al. A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II. DIABETES TECHNOLOGY & THERAPEUTICS 2018; 20(3):197-206
3. Garg, Satish K., et al. “Evaluation of accuracy and safety of the next-generation up to 180-day long-term implantable Eversense continuous glucose monitoring system: The promise study.” Diabetes Technology & Therapeutics, vol. 24, no. 2, 1 Feb. 2022, pp. 84–92, https://doi.org/10.1089/dia.2021.0182.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more. For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-E3-GBL-0058